The pharmaceutical giant has yet to start analyzing data from its final clinical trial, effectively closing the door on having results this month.
https://ift.tt/2HI9iR1 https://ift.tt/2HF0awg
The pharmaceutical giant has yet to start analyzing data from its final clinical trial, effectively closing the door on having results this month.
https://ift.tt/2HI9iR1 https://ift.tt/2HF0awg
No comments:
Post a Comment